Dentsply Sirona Inc. (XRAY) News
Filter XRAY News Items
XRAY News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
XRAY News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest XRAY News From Around the Web
Below are the latest news stories about DENTSPLY SIRONA INC that investors may wish to consider to help them evaluate XRAY as an investment opportunity.
Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceCHARLOTTE, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 15, 2025, at 7:30 am PT (10:30 am ET). Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at |
DENTSPLY SIRONA (NASDAQ:XRAY) investors are sitting on a loss of 65% if they invested three years agoThe truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term... |
Dentsply Sirona Declares Quarterly Cash DividendCHARLOTTE, N.C., Dec. 13, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on January 10, 2025, to holders of record as of December 27, 2024. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with ov |
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. During its second-quarter earnings release, the company announced it is exploring strategic options, including a sale or merger, to boost shareholder value. William Blair notes that based on Patient Square Capital’s portfolio, which doesn’t include dental or animal health companies, regulator |
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio NowXRAY continues to gain traction from a robust product portfolio. However, the suspension of Byte's business and macroeconomic factors, such as weakened global demand, persist. |
Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$19.46?DENTSPLY SIRONA Inc. ( NASDAQ:XRAY ), is not the largest company out there, but it saw a decent share price growth of... |
Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceCHARLOTTE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 7th Annual Evercore ISI HealthCONx Conference. Management is scheduled to participate in a fireside chat discussion on December 5, 2024, at 8:20 am ET. Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona we |
Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial OfficerCHARLOTTE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Herman V. Cueto, a seasoned healthcare executive, has been appointed Interim Chief Financial Officer, effective immediately. He brings over two decades of experience leading and working in finance organizations across the healthcare industry. Mr. Cueto will oversee the finance organization while Dentsply Sirona completes its ongoing search for the Compa |
Dentsply (XRAY) International Revenue Performance ExploredEvaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance. |
DENTSPLY SIRONA Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsDENTSPLY SIRONA ( NASDAQ:XRAY ) Third Quarter 2024 Results Key Financial Results Revenue: US$951.0m (flat on 3Q 2023... |